Literature DB >> 15711820

Synbiotics reduce postoperative infectious complications: a randomized controlled trial in biliary cancer patients undergoing hepatectomy.

Hidetoshi Kanazawa1, Masato Nagino, Satoshi Kamiya, Shunichiro Komatsu, Toshihiko Mayumi, Kenji Takagi, Takashi Asahara, Koji Nomoto, Ryuichiro Tanaka, Yuji Nimura.   

Abstract

BACKGROUND AND AIMS: The clinical value of synbiotics in surgical patients remains unclear. The aim of this study was to investigate the effect of synbiotics on intestinal integrity and microflora, as well as on surgical outcome, in patients undergoing high-risk hepatectomy.
METHODS: Fifty-four patients with biliary cancer were randomly allocated to two groups before hepatectomy. One group received postoperative enteral feeding that included synbiotics; the other received enteral feeding only. Lactulose/mannitol (L/M) ratio, serum diamine oxidase (DAO) activity, and fecal microflora and organic acid concentrations were determined. Postoperative infectious complications were recorded.
RESULTS: Of the 54 patients, 44 completed the trial (21 receiving synbiotics and 23 others as controls). Postoperative changes in L/M ratios and serum DAO activities were identical between the two groups. Numbers of beneficial bacteria increased in the synbiotics group after surgery but decreased in controls. Numbers of harmful microorganisms decreased in the synbiotics group but increased in controls. Total organic acid concentrations increased in the synbiotics group but decreased in controls. Incidence of infectious complications was 19% (4/21) in the synbiotics group and 52% (12/23) in controls (P<0.05). All study patients tolerated surgery (mortality 0%).
CONCLUSIONS: Synbiotics, combined with early enteral nutrition, can reduce postoperative infections. This beneficial effect presumably involves correction of an intestinal microbial imbalance induced by surgical stress.

Entities:  

Mesh:

Year:  2005        PMID: 15711820     DOI: 10.1007/s00423-004-0536-1

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  37 in total

Review 1.  Probiotics in human medicine.

Authors:  R Fuller
Journal:  Gut       Date:  1991-04       Impact factor: 23.059

2.  Early administration of Bifidobacterium breve to preterm infants: randomised controlled trial.

Authors:  H Kitajima; Y Sumida; R Tanaka; N Yuki; H Takayama; M Fujimura
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-03       Impact factor: 5.747

3.  Inhibitory effect of oral administration of Lactobacillus casei on 3-methylcholanthrene-induced carcinogenesis in mice.

Authors:  A Takagi; T Matsuzaki; M Sato; K Nomoto; M Morotomi; T Yokokura
Journal:  Med Microbiol Immunol       Date:  1999-12       Impact factor: 3.402

4.  Total artificial nutrition is associated with major changes in the fecal flora.

Authors:  S M Schneider; P Le Gall; F Girard-Pipau; T Piche; A Pompei; J L Nano; X Hébuterne; P Rampal
Journal:  Eur J Nutr       Date:  2000-12       Impact factor: 5.614

Review 5.  Surgical treatment in proximal bile duct cancer. A single-center experience.

Authors:  R Pichlmayr; A Weimann; J Klempnauer; K J Oldhafer; H Maschek; G Tusch; B Ringe
Journal:  Ann Surg       Date:  1996-11       Impact factor: 12.969

6.  Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E(1) and E(2) production by intestinal myofibroblasts.

Authors:  L E M Willemsen; M A Koetsier; S J H van Deventer; E A F van Tol
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

7.  Capillary gas chromatographic profiling of urinary, plasma and erythrocyte sugars and polyols as their trimethylsilyl derivatives, preceded by a simple and rapid prepurification method.

Authors:  G Jansen; F A Muskiet; H Schierbeek; R Berger; W van der Slik
Journal:  Clin Chim Acta       Date:  1986-06-30       Impact factor: 3.786

8.  Colistin-oxolinic acid-blood agar: a new selective medium for streptococci.

Authors:  D N Petts
Journal:  J Clin Microbiol       Date:  1984-01       Impact factor: 5.948

9.  Sensitive colorimetric assay of serum diamine oxidase.

Authors:  K Takagi; M Nakao; Y Ogura; T Nabeshima; A Kunii
Journal:  Clin Chim Acta       Date:  1994-04       Impact factor: 3.786

10.  Logistic regression and discriminant analyses of hepatic failure after liver resection for carcinoma of the biliary tract.

Authors:  M Nagino; Y Nimura; N Hayakawa; J Kamiya; S Kondo; R Sasaki; N Hamajima
Journal:  World J Surg       Date:  1993 Mar-Apr       Impact factor: 3.352

View more
  52 in total

Review 1.  Preoperative biliary drainage before resection for hilar cholangiocarcinoma: whether or not? A systematic review.

Authors:  Fei Liu; Ya Li; Yonggang Wei; Bo Li
Journal:  Dig Dis Sci       Date:  2010-07-16       Impact factor: 3.199

2.  Impact of perioperative probiotic treatment for surgical site infections in patients with colorectal cancer.

Authors:  Naoya Aisu; Shu Tanimura; Yuichi Yamashita; Kanefumi Yamashita; Kenji Maki; Yoichiro Yoshida; Takamitsu Sasaki; Shinsuke Takeno; Seiichiro Hoshino
Journal:  Exp Ther Med       Date:  2015-07-15       Impact factor: 2.447

3.  Preoperative biliary drainage before resection for cholangiocarcinoma (Pro).

Authors:  Y Nimura
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

4.  Dramatic changes of the gut flora immediately after severe and sudden insults.

Authors:  Mineji Hayakawa; Takashi Asahara; Naomi Henzan; Hiromoto Murakami; Hiroshi Yamamoto; Nobutaka Mukai; Yousuke Minami; Masahiro Sugano; Nobuhiko Kubota; Shinji Uegaki; Hisako Kamoshida; Atsushi Sawamura; Koji Nomoto; Satoshi Gando
Journal:  Dig Dis Sci       Date:  2011-03-08       Impact factor: 3.199

Review 5.  Probiotics in hepatology.

Authors:  Jan Lata; Jana Jurankova; Marcela Kopacova; Petr Vitek
Journal:  World J Gastroenterol       Date:  2011-06-28       Impact factor: 5.742

6.  Efficacy of perioperative synbiotics treatment for the prevention of surgical site infection after laparoscopic colorectal surgery: a randomized controlled trial.

Authors:  Shunichiro Komatsu; Eiji Sakamoto; Shinji Norimizu; Yuji Shingu; Takashi Asahara; Koji Nomoto; Masato Nagino
Journal:  Surg Today       Date:  2015-05-02       Impact factor: 2.549

Review 7.  Gut microbiota and bacterial translocation in digestive surgery: the impact of probiotics.

Authors:  Shunichiro Komatsu; Yukihiro Yokoyama; Masato Nagino
Journal:  Langenbecks Arch Surg       Date:  2017-03-20       Impact factor: 3.445

Review 8.  Curative-intent surgery for hilar cholangiocarcinoma: prognostic factors for clinical decision making.

Authors:  Irinel Popescu; Traian Dumitrascu
Journal:  Langenbecks Arch Surg       Date:  2014-05-20       Impact factor: 3.445

9.  Protective Effect of a Synbiotic against Multidrug-Resistant Acinetobacter baumannii in a Murine Infection Model.

Authors:  Takashi Asahara; Akira Takahashi; Norikatsu Yuki; Rumi Kaji; Takuya Takahashi; Koji Nomoto
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

10.  Impact of perioperative symbiotic therapy on infectious morbidity after Hpb Surgery in jaundiced patients: a randomized controlled trial.

Authors:  N Russolillo; A Ferrero; L Vigano'; S Langella; A Briozzo; M Ferlini; M Migliardi; L Capussotti
Journal:  Updates Surg       Date:  2014-08-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.